Page 27 - Jeff Baxter News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Elvis (the helicopter) is cheating death by becoming a drone Kelsey Atherton © Provided by Popular Science Elvis is on the right. The makers of an old workhorse helicopter named Elvis are converting their venerable flying machine into an autonomous robot. Aircraft maker Erickson and helicopter giant Sikorsky are working together to retrofit the cargo helicopter into a flying robot, one that could both fight forest fires and resupply military missions, all without risking the life of an onboard pilot. Elvis is an S-64 Air Crane, the commercial adaption of a military cargo he...

(2) Up to $33m of funding will support development of VBI's enveloped virus-like particle (eVLP) vaccine candidates against COVID-19 variants of concern. Phase 1 clinical study of VBI's eVLP vaccine candidate, VBI-2905, targeting the B.1.351 variant, anticipated to initiate mid-year 2021. CEPI, the Coalition for Epidemic Preparedness Innovations, and VBI Vaccines Inc. (Nasdaq: VBIV), today announced a partnership to develop VBI's enveloped virus like particle (eVLP) vaccine candidates against SARS-CoV-2 variants, including the B.1.351 variant, also known as 501Y.V2, first identified in South ...

By Michael Matarazzo EDITOR’S NOTE: The following is the first in a month-long series about noteworthy women in Everett, taken from vignettes written by former City Clerk Michael Matarazzo in his book ‘They Came from Everett.’ The histories of many female residents of Everett might surprise readers, as many of their stories have never been fully told. Matarazzo’s book is available at bookblues.com. Arranger/Producer/Composer Alan Lorber had an impressive resume having worked with Phil Spector, Neil Sedaka, Gene Pitney, the Coasters, Connie Francis, Jackie Wilson, etc. He was also cred...

(Getty/FG Trade) The Coalition for Epidemic Preparedness Innovations (CEPI) is funneling $33 million into VBI Vaccines so it can get to work on prepping for new and emerging variants of SARS-CoV-02 that could lessen the efficacy of authorized vaccines. The funding will go toward VBI’s enveloped viruslike particle (eVLP) vaccine candidates against COVID-19 “variants of concern,” i.e., ones that may be able to escape the current crop of vaccines and drugs. A phase 1 test of VBI’s eVLP vaccine candidate, known as VBI-2905 and targeting the B.1.351 variant (first discovered in S...

It's the first time in a quarter-century that the band has toured with some of the most acclaimed members in its 51-year history.